Terug
Ook genoteerd als
TCHBF
OTC
Dagbereik
€ 36,00
€ 38,38
52-Weeksbereik
€ 36,00
€ 83,50
Volume
17
50D / 200D Gem.
€ 36,00
/
€ 36,00
Vorige Slotkoers
€ 36,00
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -21,6 | 0,4 |
| P/B | 2,0 | 2,9 |
| ROE % | -8,2 | 3,8 |
| Net Margin % | -12,5 | 3,9 |
| Rev Growth 5Y % | -2,9 | 10,0 |
| D/E | 0,2 | 0,2 |
Belangrijkste Punten
Revenue declined -2,86% annually over 5 years
Earnings declined -256,18% over the past year
Debt/Equity of 0,19 — conservative balance sheet
Generating 102,67M in free cash flow
PEG of 0,07 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 6,93%
Groei
Revenue Growth (5Y)
-2,86%
Revenue (1Y)-9,79%
Earnings (1Y)-256,18%
FCF Growth (3Y)-9,60%
Kwaliteit
Return on Equity
-8,17%
ROIC2,21%
Net Margin-12,54%
Op. Margin4,78%
Veiligheid
Debt / Equity
0,19
Current Ratio2,46
Interest Coverage4,29
Waardering
P/E Ratio
-21,63
P/B Ratio1,99
EV/EBITDA57,80
Dividend Yield0,02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -9,79% | Revenue Growth (3Y) | -11,43% |
| Earnings Growth (1Y) | -256,18% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -2,86% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 842,81M | Net Income (TTM) | -105,68M |
| ROE | -8,17% | ROA | -6,22% |
| Gross Margin | 35,22% | Operating Margin | 4,78% |
| Net Margin | -12,54% | Free Cash Flow (TTM) | 102,67M |
| ROIC | 2,21% | FCF Growth (3Y) | -9,60% |
| Safety | |||
| Debt / Equity | 0,19 | Current Ratio | 2,46 |
| Interest Coverage | 4,29 | Dividend Yield | 0,02% |
| Valuation | |||
| P/E Ratio | -21,63 | P/B Ratio | 1,99 |
| P/S Ratio | 2,71 | PEG Ratio | 0,07 |
| EV/EBITDA | 57,80 | Dividend Yield | 0,02% |
| Market Cap | 2,29B | Enterprise Value | 2,33B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 842,81M | 934,28M | 1,07B | 1,14B | 946,62M |
| Net Income | -105,68M | 67,66M | 132,08M | 121,13M | 121,66M |
| EPS (Diluted) | -1,67 | 1,05 | 2,06 | 1,89 | 1,98 |
| Gross Profit | 296,87M | 320,60M | 390,47M | 405,32M | 388,02M |
| Operating Income | 40,28M | 75,57M | 135,97M | 145,95M | 141,13M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,70B | 2,12B | 2,07B | 2,12B | 2,00B |
| Total Liabilities | 546,60M | 686,15M | 725,06M | 758,46M | 771,29M |
| Shareholders' Equity | 1,15B | 1,44B | 1,35B | 1,36B | 1,22B |
| Total Debt | 218,33M | 321,35M | 316,09M | 307,68M | 313,66M |
| Cash & Equivalents | 176,37M | 154,19M | 132,97M | 111,44M | 121,01M |
| Current Assets | 711,74M | 856,31M | 850,57M | 803,53M | 671,86M |
| Current Liabilities | 288,75M | 531,25M | 296,91M | 336,34M | 306,37M |